Thank you dear subscribers, we are overwhelmed with your response.
Your Turn is a unique section from ThePrint featuring points of view from its subscribers. If you are a subscriber, have a point of view, please send it to us. If not, do subscribe here: https://theprint.in/subscribe/
The India-United States trade deal has been among the most debated policy developments in recent weeks. Negotiations unfolded under visible political pressure from Washington, a dynamic that many in New Delhi viewed as unusually forceful for a country officially described as a strategic partner. The headline outcome – reducing reciprocal U.S. tariffs on Indian goods to 18% – has been presented domestically as a diplomatic success. From an economic perspective, however, the material gains appear limited when assessed against regional competitors.
Tariffs in a Crowded Indo-Pacific Market
The 18% tariff rate is only marginally lower than those applied to other Indo-Pacific exporters. Vietnam faces tariffs of approximately 20%, Bangladesh around 19%, while Japan and South Korea are subject to rates closer to 15%. China, despite being framed as Washington’s principal geopolitical competitor, currently faces a nominal reciprocal tariff rate of about 10%. However additional trade restrictions are likely to raise China’s tariff burden to around 30%. In practical terms, India’s advantage over many competitors may amount to only two to three percentage points in several sectors.
In the apparel sector, valued at roughly $120 billion annually in U.S. imports, India exports about $9 billion, accounting for approximately 7% of the market. Vietnam exports over $22 billion, Bangladesh around $11 billion, and China, despite tariff pressures, continues to ship more than $25 billion.
Electronics and electrical machinery present an even starker contrast. U.S. imports in this category exceed $500 billion annually, yet India’s exports remain relatively small, at an estimated $11-13 billion. Vietnam exports more than $43 billion in electronics to the U.S. market, while China’s shipments remain above $120 billion.
Pharmaceuticals are frequently cited as a comparative strength for India. The United States imports more than $230 billion worth of pharmaceutical products annually, and Indian firms supply roughly $13 billion in finished formulations and active pharmaceutical ingredients, accounting for nearly 40% of U.S. generic prescriptions by volume. Historically, tariffs in this sector were minimal but since October 2025, however, the U.S. has imposed a 100% tariff on branded and patented drugs to incentivize domestic manufacturing. These measures appear unchanged under the trade deal, limiting its relevance for Indian pharmaceutical exporters.
With Indian goods exports to the U.S. totaling approximately $86 billion annually, even an optimistic export expansion of 6-8% under improved tariff certainty would generate an additional $5-7 billion in exports. After accounting for imported inputs, exchange-rate effects, and trade elasticity, the net impact on India’s GDP is estimated at around 0.15-0.3%. For an economy approaching $4 trillion, the gain is measurable but far from transformative.
Cost of Alignment
Parallel to trade discussions, political attention has focused on India’s purchases of Russian crude oil. India imports roughly 5.2 million barrels of oil per day, amounting to nearly 1.9 billion barrels annually. In recent years, approximately 35% of these imports have come from Russia.
Russian Urals crude has typically traded at a discount of about $8-10 per barrel relative to Brent benchmarks. At an average discount of $8, India’s annual savings on roughly 550-600 million barrels could approach $5 billion, rising toward $6 billion when discounts widen. Additional expenses could be incurred due to freight and insurance costs associated with Atlantic routes, as well as technical adjustments to refineries. These costs are comparable to the projected export gains resulting from tariff relief.
Concerns are further amplified by indications that India may reduce or eliminate tariffs on a wide range of U.S. industrial and agricultural goods. In agriculture, U.S. producers of corn, soybeans, dairy, and processed foods combine high productivity with extensive federal support mechanisms. Increased access to the Indian market could exert downward pressure on domestic prices in sensitive categories, affecting millions of smallholder farmers. With agriculture supporting more than 46% of India’s workforce, the distributional consequences could be substantial, even if consumers see modest price declines.
Benefit First, Pressure Last
The broader policy environment also warrants consideration. U.S. trade policy in recent years has been marked by volatility. Any tariff advantage secured today could be eroded if Washington extends similar concessions to competing Asian exporters or introduces new measures in response to domestic political cycles. The unpredictable nature of the Trump administration was evident once again last Friday. The U.S. President threatened to impose 200% tariffs on both New Delhi and Islamabad if they did not stop the controversy. As a result, projected export gains remain inherently uncertain.
Taken together, the agreement offers India limited but tangible economic benefits while exposing it to potentially higher energy costs and intensified domestic competition. At the Munich Security Conference in February 2026, External Affairs Minister S. Jaishankar underscored that India’s decisions would be guided by calculations of economic interest and national priorities rather than external pressure. The durability of that principle may ultimately determine whether the trade deal proves advantageous beyond its headline figures.
These pieces are being published as they have been received – they have not been edited/fact-checked by ThePrint.